Patents by Inventor Derek Franklin

Derek Franklin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES THAT BIND TNFRSF25
    Publication number: 20260265395
    Abstract: Provided herein are antibodies and antibody fragments that bind to human TNFRSF25. The antibodies may be monoclonal and/or biparatopic antibodies and/or single-chain fragment variable (scFv) antibodies. Methods of treating or preventing diseases or disorders associated with inflammation and/or autoimmunity are provided, comprising administering to a patient in need thereof an effective amount of a human TNFRSF25-binding antibody.
    Type: Application
    Filed: October 8, 2025
    Publication date: September 10, 2026
    Applicant: SHATTUCK LABS, INC.
    Inventors: Suresh DE SILVA, Mahmud HUSSAIN, Anne LAI, Derek FRANKLIN, Taylor SCHREIBER
  • Antibodies that bind TNFRSF25
    Patent number: 12460010
    Abstract: Provided herein are antibodies and antibody fragments that bind to human TNFRSF25. The antibodies may be monoclonal and/or biparatopic antibodies and/or single-chain fragment variable (scFv) antibodies. Methods of treating or preventing diseases or disorders associated with inflammation and/or autoimmunity are provided, comprising administering to a patient in need thereof an effective amount of a human TNFRSF25-binding antibody.
    Type: Grant
    Filed: May 5, 2025
    Date of Patent: November 4, 2025
    Assignee: SHATTUCK LABS, INC.
    Inventors: Suresh De Silva, Mahmud Hussain, Anne Lai, Derek Franklin, Taylor Schreiber
  • ANTIBODIES THAT BIND TNFRSF25
    Publication number: 20250277049
    Abstract: Provided herein are antibodies and antibody fragments that bind to human TNFRSF25. The antibodies may be monoclonal and/or biparatopic antibodies and/or single-chain fragment variable (scFv) antibodies. Methods of treating or preventing diseases or disorders associated with inflammation and/or autoimmunity are provided, comprising administering to a patient in need thereof an effective amount of a human TNFRSF25-binding antibody.
    Type: Application
    Filed: May 5, 2025
    Publication date: September 4, 2025
    Applicant: SHATTUCK LABS, INC.
    Inventors: Suresh DE SILVA, Mahmud HUSSAIN, Anne LAI, Derek FRANKLIN, Taylor SCHREIBER
  • Antibodies that bind TNFRSF25
    Patent number: 12319742
    Abstract: Provided herein are antibodies and antibody fragments that bind to human TNFRSF25. The antibodies may be monoclonal and/or biparatopic antibodies and/or single-chain fragment variable (scFv) antibodies. Methods of treating or preventing diseases or disorders associated with inflammation and/or autoimmunity are provided, comprising administering to a patient in need thereof an effective amount of a human TNFRSF25-binding antibody.
    Type: Grant
    Filed: January 24, 2025
    Date of Patent: June 3, 2025
    Assignee: SHATTUCK LABS, INC.
    Inventors: Suresh De Silva, Mahmud Hussain, Anne Lai, Derek Franklin, Taylor Schreiber